Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Equity Ratio (2016 - 2022)

Historic Equity Ratio for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to 0.09.

  • Avadel Pharmaceuticals' Equity Ratio fell 12277.68% to 0.09 in Q3 2022 from the same period last year, while for Sep 2022 it was 0.09, marking a year-over-year decrease of 12277.68%. This contributed to the annual value of 0.32 for FY2021, which is 3922.71% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Equity Ratio stood at 0.09 for Q3 2022, which was down 12277.68% from 0.02 recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Equity Ratio peaked at 0.53 during Q2 2020, and registered a low of 0.19 during Q4 2019.
  • In the last 5 years, Avadel Pharmaceuticals' Equity Ratio had a median value of 0.24 in 2018 and averaged 0.18.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Equity Ratio plummeted by 141987.51% in 2019 and then skyrocketed by 59727.02% in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Equity Ratio stood at 0.01 in 2018, then crashed by 1419.88% to 0.19 in 2019, then surged by 370.05% to 0.52 in 2020, then tumbled by 39.23% to 0.32 in 2021, then tumbled by 126.97% to 0.09 in 2022.
  • Its last three reported values are 0.09 in Q3 2022, 0.02 for Q2 2022, and 0.25 during Q1 2022.